Craig J Thomas Selected Research

Craig J Thomas Research Topics

Disease

51	Neoplasms (Cancer) 06/2022 - 03/2005
5	Rhabdomyosarcoma 01/2021 - 08/2013
5	Breast Neoplasms (Breast Cancer) 11/2018 - 01/2006
4	Carcinogenesis 06/2022 - 10/2012
4	Treatment-Resistant Depressive Disorder 11/2021 - 01/2019
4	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 01/2014
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 02/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 06/2014
3	Leukemia 01/2018 - 02/2011
3	Lymphoma (Lymphomas) 12/2017 - 01/2010
3	Lung Neoplasms (Lung Cancer) 11/2017 - 12/2011
3	Schistosomiasis (Bilharziasis) 10/2009 - 01/2008
2	Adenocarcinoma 01/2022 - 01/2022
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2021
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 10/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2019
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2019
2	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2021 - 12/2020
2	Neuroblastoma 01/2021 - 11/2015
2	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 12/2017
2	Tuberculosis (Tuberculoses) 12/2019 - 01/2016
2	Glioma (Gliomas) 11/2019 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 12/2017
2	Schizophrenia (Dementia Praecox) 01/2016 - 07/2012
2	Marfan Syndrome (Marfan's Syndrome) 10/2015 - 04/2011
2	Thyroid Neoplasms (Thyroid Cancer) 07/2010 - 07/2009
2	Hyperthyroidism 07/2010 - 12/2008
1	Rare Diseases (Rare Disease) 12/2022
1	Substance-Related Disorders (Drug Abuse) 10/2022
1	COVID-19 06/2022
1	Neurofibrosarcoma (MPNST) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Complex Regional Pain Syndromes 01/2022
1	Genomic Instability 12/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021
1	Neuroinflammatory Diseases 01/2021

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 12/2022 - 01/2008
9	EnzymesIBA 12/2021 - 03/2005
8	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2009
8	Pyruvate KinaseIBA 01/2022 - 02/2010
8	Protein Isoforms (Isoforms)IBA 01/2018 - 02/2010
7	Phosphotransferases (Kinase)IBA 12/2020 - 05/2008
6	EsketamineIBA 01/2022 - 10/2018
6	Drug CombinationsIBA 12/2020 - 10/2012
5	Ketamine FDA LinkGeneric 10/2022 - 10/2018
4	ibrutinibIBA 11/2021 - 02/2014
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2022 - 01/2018
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 10/2018
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021 - 03/2005
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2017
3	Histones (Histone)IBA 11/2019 - 12/2010
3	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 03/2005
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2015 - 01/2006
2	6-hydroxynorketamineIBA 10/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2018
2	Agammaglobulinaemia Tyrosine KinaseIBA 11/2021 - 12/2017
2	CytokinesIBA 01/2021 - 04/2015
2	Interleukin-2 (IL2)IBA 01/2021 - 10/2015
2	trametinibIBA 01/2021 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 08/2013
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2020 - 12/2017
2	Glutamine (L-Glutamine)FDA Link 11/2018 - 10/2017
2	GlutaminaseIBA 11/2018 - 11/2017
2	Aspartic Acid (Aspartate)FDA Link 11/2018 - 11/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 12/2011
2	ruxolitinibIBA 02/2016 - 10/2015
2	navitoclaxIBA 02/2016 - 10/2015
2	Neuregulin-1 (Neuregulin 1)IBA 01/2016 - 07/2012
2	Interleukin-15 (Interleukin 15)IBA 10/2015 - 08/2013
2	1- (4- dimethylaminomethylphenyl)- 8,9- dihydro- 7H- 2,7,9a- benzo(cd)azulen- 6- oneIBA 06/2014 - 01/2006
2	Biological ProductsIBA 07/2012 - 02/2011
2	IsoenzymesIBA 11/2011 - 02/2010
2	Tyrosine (L-Tyrosine)FDA Link 04/2011 - 12/2010
2	tofacitinibIBA 04/2011 - 02/2011
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 07/2010 - 12/2008
1	SNX 2112IBA 06/2022
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	SARS-CoV-2 3C-like proteinaseIBA 06/2022
1	torinIBA 01/2022
1	carfilzomibIBA 01/2022
1	Methionine Sulfoxide ReductasesIBA 01/2022
1	PanobinostatIBA 01/2022
1	NexusIBA 01/2022
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	adavosertibIBA 01/2022
1	PlatinumIBA 12/2021
1	Histocompatibility Antigens Class IIBA 12/2021
1	Phospholipases (Phospholipase)IBA 11/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	ON 01910IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Vinca AlkaloidsIBA 01/2021
1	upadacitinibIBA 01/2021

Therapy/Procedure

17	Therapeutics 12/2022 - 01/2008
7	Drug Therapy (Chemotherapy) 11/2019 - 03/2005
1	Treatment Delay 01/2021